Inactivation Effect of Violet and Blue Light on ESKAPE Pathogens and Closely Related Non-pathogenic Bacterial Species – A Promising Tool Against Antibiotic-Sensitive and Antibiotic-Resistant Microorganisms

@article{Hoenes2021InactivationEO,
  title={Inactivation Effect of Violet and Blue Light on ESKAPE Pathogens and Closely Related Non-pathogenic Bacterial Species – A Promising Tool Against Antibiotic-Sensitive and Antibiotic-Resistant Microorganisms},
  author={Katharina Hoenes and Richard J. Bauer and Tobias Meurle and Barbara Spellerberg and Martin Hessling},
  journal={Frontiers in Microbiology},
  year={2021},
  volume={11}
}
Due to the globally observed increase in antibiotic resistance of bacterial pathogens and the simultaneous decline in new antibiotic developments, the need for alternative inactivation approaches is growing. This is especially true for the treatment of infections with the problematic ESKAPE pathogens, which include Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species, and often exhibit multiple antibiotic… 

Figures and Tables from this paper

The effects of violet and blue light irradiation on ESKAPE pathogens and human cells in presence of cell culture media

A significant reduction of viable bacteria could be achieved at subtoxic irradiation doses, supporting a potential use of visible light as an antimicrobial agent in clinical settings.

Visualization and elimination of polymicrobial biofilms by a combination of ALA-carvacrol-blue light.

  • Yongli LiMei-Xi Wu
  • Biology, Medicine
    Journal of photochemistry and photobiology. B, Biology
  • 2022

Reversal of Polymicrobial Biofilm Tolerance to Ciprofloxacin by Blue Light plus Carvacrol

It is suggested that bacterial membrane damage can be one of the pivotal strategies to subvert biofilm tolerance and combat the recalcitrant multispecies biofilms.

Can Gram-Negative Bacteria Develop Resistance to Antimicrobial Blue Light Treatment?

It is demonstrated that representative Gram-negative bacteria may develop tolerance to aBL and the observed adaption was a stable feature.

Genetic Factors Affect the Survival and Behaviors of Selected Bacteria during Antimicrobial Blue Light Treatment

Evidence of inherent factors that may confer protection to a selected group of bacteria against blue light-induced oxidative damages or modulate the physiological characteristics of the treated bacteria, such as virulence and motility is summarized.

Photoinactivation of Staphylococci with 405 nm Light in a Trachea Model with Saliva Substitute at 37 °C

It is proved that photoinactivation at 37 °C is more effective with a reduction of almost 3 log levels compared to 25 °C, which might be caused by a less favorable environment for bacteria due to for example the ionic composition.

Microbial Photoinactivation by Visible Light Results in Limited Loss of Membrane Integrity

It is suggested that visible light photoinactivation does not lead to rapid bacterial cell lysis or disruption, however, functional loss of membrane integrity due to depolarization or inactivation of membrane proteins may occur.

Bacterial and Viral Pathogens, Molecular Mechanisms and Cellular Toxicity

Viruses as pathogens have ability to replicate in the particular host in order to damage their organs and there is need to design such drugs that control the specific targets of bacterial strains.

Blue light inactivation of the enveloped RNA virus Phi6

The results support speculations about blue-susceptibility of coronaviruses, which might allow to employ blue light for infection prevention or even therapeutic applications.

Minimum irradiance required to inhibit microbial growth to prevent ventilatorassociated pneumonia by an endotracheal tube equipped with blue LEDs

The aim of this study was to find the minimal required irradiance for microbial reduction of 1 log level in 24 h by applying LED-ETTs, which are expected to reduce A. kookii without harming human tracheal cells.

References

SHOWING 1-10 OF 79 REFERENCES

Antibacterial Activity of Blue Light against Nosocomial Wound Pathogens Growing Planktonically and as Mature Biofilms

Blue light shows great promise as a novel decontamination strategy for the nosocomial environment, as well as additional wider decontaminations applications (e.g., wound closure during surgery).

Characterization of blue light irradiation effects on pathogenic and nonpathogenic Escherichia coli

Blue light irradiation is not bactericidal, but can retard E. coli growth in a manner that is dependent on culture age and strain background, given that bacteria on and within mammalian hosts are found in different phases of growth.

Inactivation of staphylococcal virulence factors using a light-activated antimicrobial agent

Light-activated antimicrobial agent methylene blue in combination with laser light of 665 nm is used to inactivate staphylococcal virulence factors and suggests that photodynamic therapy could reduce the harmful impact of preformed virulence Factors on the host.

Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review

The objective of this review is to describe the alternative therapies reported to treat ESKAPE infections, their advantages and limitations, potential application in vivo, and status in clinical trials.

A comparative in vitro photoinactivation study of clinical isolates of multidrug-resistant pathogens

The authors' studied MRSA isolate responded better than S. aureus, and pL-ce6-mediated PDI in other MRSA isolates deserves further investigation.

Inactivation of Bacterial Pathogens following Exposure to Light from a 405-Nanometer Light-Emitting Diode Array

ABSTRACT This study demonstrates the susceptibility of a variety of medically important bacteria to inactivation by 405-nm light from an array of light-emitting diodes (LEDs), without the application

Antimicrobial resistance.

Therapeutic options available to treat serious infections caused by these extensively drug-resistant pathogens are limited to colistin, tigecycline and fosfomycin, therefore, new treatment regime must be required.

Recent Patents on Light-Based Anti-Infective Approaches.

Light-based antimicrobial approaches hold great promise for the future in regards to treating antibiotic-resistant infections and related diseases.
...